Ramdev Slams Allopathy Immediately After SC Closes Contempt Case

Haridwar: The Supreme Court of India purged the contempt case filed by the Indian Medical Association (IMA) on Baba Ramdev and aide Balkrishna over Patanjali’s misleading ads and for slandering modern medicine. Baba Ramdev issued an unconditional apology for his Ayurvedic company, Patanjali’s, misleading advertisements that claimed cures for diabetes, asthma and other maladies. In its judgment, the apex court stated that if Patanjali repeated the actions, the consequences would be grave. The court cautioned the party that although “the sword of contempt has now returned to rest in its sheath, it shall flourish as swiftly” in the event of further contempt. Earlier, the SC in April had refused to accept Baba’s apology as mere lip service. Seems like their judgment was right. Immediately after the closure of the contempt proceedings following the apology, the self-proclaimed Yog Guru launched a fresh salvo against allopathy, calling it poisonous for the common people. Ramdev jibed.

“Allopathy ki zeherili dawai kha kha ke har saal karodo logon ki maut hoti hai. (Crores of people die consuming poisonous allopathy medicines.)

He proceeded to slam the British Raj, Islam, and Lenin-Marx-Mao for murdering millions, while allopathic medicines kill innocent people every year.

At the peak of COVID, Baba Ramdev’s statement that medicos practicing modern medicine are money-minded received backlash on social media. But as one gentleman commented, ‘dum seedhi na hui’ (the tail hasn’t become straight, IYKYK).

Related Posts

  • Pharma
  • April 4, 2025
  • 100 views
Trump warns of pharma sector tariff at levels ‘never seen before’, says announcement can be expected soon

Just moments after announcing sweeping reciprocal tariffs on countries that trade with the United States, US President Donald Trump assured that the pharma sector, particularly, is being looked at as…

  • Pharma
  • April 4, 2025
  • 113 views
India’s generic medicines steal the spotlight as US exempts pharma from tariffs

India’s pharma sector has emerged as a big winner amid Trump’s tariff woes, as the US has exempted pharmaceuticals from reciprocal tariffs, recognizing the vital role of India’s generic medicines…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Trump warns of pharma sector tariff at levels ‘never seen before’, says announcement can be expected soon

Trump warns of pharma sector tariff at levels ‘never seen before’, says announcement can be expected soon

India’s generic medicines steal the spotlight as US exempts pharma from tariffs

India’s generic medicines steal the spotlight as US exempts pharma from tariffs

Is Gujarat’s Health Department Rebelling against PM Modi Government?

Is Gujarat’s Health Department Rebelling against PM Modi Government?

Nifty Pharma soars 3% on exclusion from Trump’s reciprocal tariffs; Sun Pharma, IPCA Labs up 5%

Nifty Pharma soars 3% on exclusion from Trump’s reciprocal tariffs; Sun Pharma, IPCA Labs up 5%